Welcome to our Multi-Omics Center, Israel's first platform for genomics, proteomics, metabolomics, transcriptomics, and microbiome research integrating our center unit’s expertise and cutting-edge technologies. The Multi-Omics Center was established by the Technion-Israel Institute of Technology, Ben Gurion University of the Negev (BGU), and Haifa University, and was funded by VATAT (The Planning and Budgeting Committee of the Council for Higher Education in Israel).
Our center acts as a one-stop-shop for Multi-Omics analysis, providing comprehensive support for researchers in academia, biotech, and industry from experimental design and sample preparation to advanced data integration and bioinformatics. Our goal is to empower scientists with system-level insights, accelerating discoveries across diverse fields, including environmental sustainability, food technology, agronomy and human health.
Leveraging over 15 years of experience and state-of-the-art technologies, we are committed to fostering innovation, interdisciplinary collaboration, and education, making Multi-Omics research more accessible to scientists nationwide.
Together, we are shaping the future of integrative omics research.
Services
News & Events
Visit the Technion Research Infrastructure Center at BioMed 2025
Join our exhibition booth at the in the BioMed 20 - 22 May 2025, David Inter Continental Hotel in Tel Aviv.
Meet representatives from the Technion's life sciences infrastructure facilities and discover our advanced research capabilities. We look forward to connecting with you! Learn more about BioMed 2025
New at the Multi-Omics BGU center Xevo G3 QTof System
The Xevo® G3 QTof combines technology for superior robustness, sensitivity and selectivity along with high dynamic range mass accuracy and speed of analysis, resulting in the highest quality qualitative and quantitative information. Increasing compound coverage and analytical fidelity without compromising high mass biomolecule.
Location: Ben Gurion Metabolomics Unit
New at the Multi-Omics Technion Proteograph XT nanoparticle assay and SP100 Automation system
Seer’s workflow uncovers critical insights from the dynamic and complex proteome. With the Proteograph XT nanoparticle assay and SP100 Automation system, researchers can detect rare protein variants and novel protein biomarkers in a seamless process that is accurate, precise, and reproducible for a wide variety of sample types and sizes.
Location: Smoler Proteomics Center.